FRANCISCO JAVIER MENÁRGUEZ PALANCA-rekin lankidetzan egindako argitalpenak (5)

2000

  1. Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy

    Leukemia and Lymphoma, Vol. 39, Núm. 5-6, pp. 563-572

1999

  1. Other cancers in patients with gastric MALT lymphoma

    Leukemia and Lymphoma, Vol. 33, Núm. 1-2, pp. 161-168

1997

  1. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr Virus-latent membrane protein 1 expression

    Blood, Vol. 90, Núm. 6, pp. 2429-2436

1996

  1. Evaluation of the international index in the prognosis of high grade gastric malt lymphoma

    Leukemia and Lymphoma, Vol. 24, Núm. 1-2, pp. 159-163

1995

  1. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients

    Annals of Oncology, Vol. 6, Núm. 4, pp. 355-362